Thus, both PIEZO1 pharmacological activation (as well as PIEZO1 gain-of-function mutations [20, 21]) and SCD [38, 39] cause a change in the shape of RBCs and confer a significant protection against malaria, although apparently through distinct mechanisms. Here, PIEZO1 is linked to malaria.